Submit Deal

Submit Deal

Cover Image Rafaèle Tordjman

Rafaèle Tordjman

Founder and CEO at JEITO CAPITAL

Investor

Deal Bio

Total Deals8

Valued Deals7

Total Value£ 538 M

Avg. Deal Size£ 77 M

Market Context

Sort

14 Sep 2020|Netherlands|Biotechnology

Target: NEOGENE THERAPEUTICS

Bidder: JEITO CAPITAL

11 Service Providers

2 Target | 9 Bidder

26 Dealmakers

2 Target | 24 Bidder

£ 85 M

Value

21 Oct 2020|France|Biotechnology

Target: SPARINGVISION

Bidder: FOUNDATION FIGHTING BLINDNESS

10 Service Providers

3 Target | 7 Bidder

12 Dealmakers

5 Target | 7 Bidder

£ 40 M

Value

29 Nov 2021|United Kingdom|Biotechnology

Target: QUELL THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

7 Service Providers

3 Target | 4 Bidder

12 Dealmakers

6 Target | 6 Bidder

£ 117 M

Value

13 Apr 2022|Switzerland|Pharmaceuticals

Target: CDR-LIFE INC

Bidder: OMEGA FUNDS

6 Service Providers

3 Target | 3 Bidder

12 Dealmakers

9 Target | 3 Bidder

£ 60 M

Value

14 Sep 2022|France|Biotechnology

Target: SPARINGVISION

Bidder: YSIOS CAPITAL

5 Service Providers

1 Target | 4 Bidder

6 Dealmakers

1 Target | 5 Bidder

£ 65 M

Value

01 Nov 2022|United States|Biotechnology

Target: HUMAN IMMUNOLOGY BIOSCIENCES

Bidder: ARCH VENTURE PARTNERS

5 Service Providers

1 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 104 M

Value

13 Apr 2023|Switzerland|Pharmaceuticals

Target: ALENTIS THERAPEUTICS

Bidder: PUREOS BIOVENTURES

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

n/a

Value

24 Mar 2025|Belgium|Biotechnology

Target: AUGUSTINE THERAPEUTICS NV

Bidder: V-BIO VENTURES

7 Service Providers

2 Target | 5 Bidder

9 Dealmakers

2 Target | 9 Bidder

£ 65 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite